Beloderm cream d / outside. approx. 0.05% 40g

Release form

Ointment for external use 0.05%.

Packaging

Tuba 30 g.

pharmachologic effect

GCS for external use.

It has anti-inflammatory, antipruritic, antiallergic, vasoconstrictor, antiexudative and antiproliferative effects.

When applied to the surface of the skin, the drug has a quick and strong effect in the focus of inflammation, reducing the severity of objective symptoms (erythema, edema, lichenification) and subjective sensations (itching, irritation, pain).

Indications

Conditions in which therapy with topical corticosteroids is effective, including:

- Atopic dermatitis.

- Neurodermatitis.

- Allergic contact dermatitis.

- Eczema (various forms).

- Contact dermatitis (including professional).

- Non-allergic dermatitis (including solar and radiation dermatitis).

- Reactions to insect bites.

- Psoriasis.

- Bullous dermatoses.

- Discoid lupus erythematosus.

- Lichen planus.

- Exudative erythema multiforme.

- Skin itching of various etiologies.

Contraindications

- Tuberculosis of the skin.

- Cutaneous manifestations of syphilis.

- Chickenpox.

- Viral, bacterial and fungal skin infections.

- Skin post-vaccination reactions.

- Open wounds.

- Trophic ulcers.

- Rosacea.

- Acne vulgaris.

- Tumors of the skin and subcutaneous structures.

- Children up to age 6 months.

- Hypersensitivity to betamethasone or to any of the auxiliary components of the drug.

Application during pregnancy and lactation

The use of the drug Beloderm in pregnant women is allowed in cases where the intended benefit to the mother outweighs the risk to the fetus.

In such cases, the use of the drug should be short-lived and limited to small areas of the skin.

During the period of breastfeeding, the use of the drug is possible according to strict indications, but the drug should not be applied to the skin of the breast before feeding.

special instructions

Long-term use of the drug on the skin of the face is not recommended.

development of rosacea, perioral dermatitis and acne is possible.

The drug should not be used in the eye area, due to the likelihood of getting the drug on the mucous membrane, which can contribute to the development of cataracts, glaucoma, fungal infections of the eye and exacerbation of herpes infection.

Some areas of the body, such as the armpits, inguinal folds, where natural occlusion exists, are more at risk of developing stretch marks, so the use of the drug on these areas of the skin should be short-lived.

With the development of a fungal or bacterial infection on the skin, additional use of an antibacterial or antifungal agent is necessary.

Use in pediatrics

The drug can be administered to children from 6 months of age with caution and for the shortest possible time.

Do not use the drug under bandages and, especially under plasticized diapers, because

this enhances the absorption of the drug and increases the risk of side effects.

Influence on the ability to drive vehicles and use mechanisms

There are no data on the adverse effects of Beloderm on the ability to drive vehicles and mechanisms.

Structure

1 g of ointment contains:

Active substance: betamethasone dipropionate - 640 mcg, which corresponds to the content of betamethasone - 500 mcg.

Excipients: chlorocresol, sodium dihydrogen phosphate monohydrate, phosphoric acid, petrolatum, mineral oil, macrogol cetostearate, cetostearyl alcohol (60% cetyl alcohol, 40% stearyl alcohol), sodium hydroxide, water.

Method of administration and dosage

The drug is intended for external use only.

Topical cream or ointment

Name ENG

BELOGENT

Clinical and pharmacological group

Drug with antibacterial and anti-inflammatory action for external use

ATX code

Betamethasone in combination with antibiotics

Dosage

0.05% x 30g

Structure

1 g of ointment contains: Active substance: betamethasone dipropionate - 640 μg, which corresponds to the content of betamethasone - 500 μg.

Excipients: mineral oil, petroleum jelly.

Indications

Conditions in which therapy with topical corticosteroids is effective, including:

Atopic dermatitis.

Neurodermatitis.

Allergic contact dermatitis.

Eczema (various forms).

Contact dermatitis (including professional).

Non-allergic dermatitis (including solar and radiation dermatitis).

Reactions to insect bites.

Psoriasis.

Bullous dermatoses.

Discoid lupus erythematosus.

Lichen planus.

Exudative erythema multiforme.

Itching of various etiologies.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 5 years

Contraindications

Lupus.

Cutaneous manifestations of syphilis.

Chickenpox.

Viral, bacterial and fungal skin infections.

Post-vaccination skin reactions.

Open wounds.

Trophic ulcers.

Rosacea.

Acne vulgaris.

Tumors of the skin and subcutaneous structures.

Children up to age 6 months

Hypersensitivity to betamethasone or to any of the auxiliary components of the drug.

INN / Active ingredient

betamethasone, gentamicin (sulfate form)

Specifications

Category

Psoriasis

Scope of the drug

Leather

Release form

Ointment

Manufacturer country

Croatia

Package quantity, pcs

one

Minimum age from

1 year

Way of introduction

Locally

,

On the skin

,

Outwardly

Vacation conditions

Without recipe

Brand name

Belupo

The amount of the dosage form in the primary package

30 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Topical glucocorticosteroid

Anatomical and therapeutic characteristics

D07AC01 Betamethasone

Dosage form

Ointment for external use

Expiration date in days

1826

The target audience

Children

Package weight, g

25

Mode of application

: https://translate.google.com/translate?hl=&sl=ru&tl=en&u=https://zz.buy-pharm.com/xzzakco.html;Description

Release form

Cream for external use 0.05%.

Packaging

Tube 40 g.

pharmachologic effect

GCS for external use.

It has anti-inflammatory, antipruritic, antiallergic, vasoconstrictor, antiexudative and antiproliferative effects.

When applied to the surface of the skin, the drug has a quick and strong effect in the focus of inflammation, reducing the severity of objective symptoms (erythema, edema, lichenification) and subjective sensations (itching, irritation, pain).

Indications

Conditions in which therapy with topical corticosteroids is effective, including:

- Atopic dermatitis.

- Neurodermatitis.

- Allergic contact dermatitis.

- Eczema (various forms).

- Contact dermatitis (including professional).

- Non-allergic dermatitis (including solar and radiation dermatitis).

- Reactions to insect bites.

- Psoriasis.

- Bullous dermatoses.

- Discoid lupus erythematosus.

- Lichen planus.

- Exudative erythema multiforme.

- Skin itching of various etiologies.

Contraindications

- Tuberculosis of the skin.

- Cutaneous manifestations of syphilis.

- Chickenpox.

- Viral, bacterial and fungal skin infections.

- Skin post-vaccination reactions.

- Open wounds.

- Trophic ulcers.

- Rosacea.

- Acne vulgaris.

- Tumors of the skin and subcutaneous structures.

- Children up to age 6 months.

- Hypersensitivity to betamethasone or to any of the auxiliary components of the drug.

Application during pregnancy and lactation

The use of the drug Beloderm in pregnant women is allowed in cases where the intended benefit to the mother outweighs the risk to the fetus.

In such cases, the use of the drug should be short-lived and limited to small areas of the skin.

During the period of breastfeeding, the use of the drug is possible according to strict indications, but the drug should not be applied to the skin of the breast before feeding.

special instructions

Long-term use of the drug on the skin of the face is not recommended.

development of rosacea, perioral dermatitis and acne is possible.

The drug should not be used in the eye area, due to the likelihood of getting the drug on the mucous membrane, which can contribute to the development of cataracts, glaucoma, fungal infections of the eye and exacerbation of herpes infection.

Some areas of the body, such as the armpits, inguinal folds, where natural occlusion exists, are more at risk of developing stretch marks, so the use of the drug on these areas of the skin should be short-lived.

With the development of a fungal or bacterial infection on the skin, additional use of an antibacterial or antifungal agent is necessary.

Use in pediatrics

The drug can be administered to children from 6 months of age with caution and for the shortest possible time.

Do not use the drug under bandages and, especially under plasticized diapers, because

this enhances the absorption of the drug and increases the risk of side effects.

Influence on the ability to drive vehicles and use mechanisms

There are no data on the adverse effects of Beloderm on the ability to drive vehicles and mechanisms.

Structure

1 g of cream contains:

Active substance: betamethasone dipropionate - 640 mcg, which corresponds to the content of betamethasone - 500 mcg.

Excipients: chlorocresol, sodium dihydrogen phosphate monohydrate, phosphoric acid, petrolatum, mineral oil, macrogol cetostearate, cetostearyl alcohol (60% cetyl alcohol, 40% stearyl alcohol), sodium hydroxide, water.

Method of administration and dosage

The drug is intended for external use only.

Topical cream or ointment

Name ENG

BELOGENT

Clinical and pharmacological group

Drug with antibacterial and anti-inflammatory action for external use

ATX code

Betamethasone in combination with antibiotics

Dosage

0.05% x 40g

Structure

1 g of cream contains:.

Active substance: betamethasone dipropionate - 640 mcg, which corresponds to the content of betamethasone - 500 mcg.

...

Excipients: chlorocresol, sodium dihydrogen phosphate monohydrate, phosphoric acid, petrolatum, mineral oil, macrogol cetostearate, cetostearyl alcohol (60% cetyl alcohol, 40% stearyl alcohol), sodium hydroxide, water.

INN / Active ingredient

betamethasone, gentamicin (sulfate form)

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 5 years

Specifications

Category

Psoriasis

Scope of the drug

Leather

Release form

Cream

Manufacturer country

Croatia

Package quantity, pcs

one

Minimum age from

1 year

Way of introduction

Locally

,

On the skin

,

Outwardly

Vacation conditions

Without recipe

Brand name

Belupo

The amount of the dosage form in the primary package

40 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Topical glucocorticosteroid

Anatomical and therapeutic characteristics

D07AC01 Betamethasone

Dosage form

Cream for external use

The target audience

Children

Expiration date in days

1826

Package weight, g

55

Mode of application

:

The drug is intended for external use only. < br> Cream or ointment for external use is applied to the affected area of ​​the skin with a thin layer 2 times / day, gently rubbing. For areas with denser skin (for example, elbows, palms and feet), or where the product is easy to wear off, the product can be applied more frequently. The duration of continuous treatment is usually no more than 4 weeks. < br> < br> To prevent relapses in the treatment of chronic diseases, therapy should be continued for some time after the disappearance of all symptoms. < br> < br> Repeated courses of therapy are possible during the year. < br> < br> Cream for external use is used for the treatment of acute, incl. weeping skin lesions.

Information on technical characteristics, delivery set, country of manufacture "